FERLAZZO, Guido
 Distribuzione geografica
Continente #
EU - Europa 8.132
NA - Nord America 6.344
AS - Asia 3.912
SA - Sud America 1.268
AF - Africa 109
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 5
Totale 19.777
Nazione #
US - Stati Uniti d'America 6.223
RU - Federazione Russa 4.186
SG - Singapore 1.600
CN - Cina 1.213
BR - Brasile 1.109
IE - Irlanda 854
SE - Svezia 764
IT - Italia 664
HK - Hong Kong 432
DE - Germania 318
UA - Ucraina 300
PL - Polonia 265
FR - Francia 240
VN - Vietnam 220
FI - Finlandia 152
GB - Regno Unito 150
IN - India 106
AR - Argentina 58
MX - Messico 52
BE - Belgio 44
CA - Canada 44
BD - Bangladesh 42
TR - Turchia 42
AT - Austria 41
ZA - Sudafrica 41
CZ - Repubblica Ceca 34
JP - Giappone 32
NL - Olanda 31
IQ - Iraq 30
ID - Indonesia 28
EC - Ecuador 24
ES - Italia 23
MA - Marocco 21
PK - Pakistan 19
UZ - Uzbekistan 19
CO - Colombia 17
SA - Arabia Saudita 17
PY - Paraguay 16
VE - Venezuela 15
TN - Tunisia 12
CL - Cile 11
KR - Corea 11
LT - Lituania 10
PH - Filippine 10
AE - Emirati Arabi Uniti 9
IR - Iran 9
NP - Nepal 9
AZ - Azerbaigian 8
KE - Kenya 8
KZ - Kazakistan 8
MY - Malesia 8
BO - Bolivia 7
EG - Egitto 7
IL - Israele 7
AL - Albania 6
RS - Serbia 6
UY - Uruguay 6
CR - Costa Rica 5
EE - Estonia 5
PE - Perù 5
RO - Romania 5
AU - Australia 4
BY - Bielorussia 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
ET - Etiopia 4
GR - Grecia 4
JM - Giamaica 4
JO - Giordania 4
LU - Lussemburgo 4
LV - Lettonia 4
OM - Oman 4
CI - Costa d'Avorio 3
KH - Cambogia 3
LB - Libano 3
NZ - Nuova Zelanda 3
PA - Panama 3
TH - Thailandia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
BA - Bosnia-Erzegovina 2
DK - Danimarca 2
EU - Europa 2
GA - Gabon 2
GT - Guatemala 2
HN - Honduras 2
HU - Ungheria 2
LA - Repubblica Popolare Democratica del Laos 2
MD - Moldavia 2
NI - Nicaragua 2
PS - Palestinian Territory 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
AG - Antigua e Barbuda 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BT - Bhutan 1
BW - Botswana 1
CH - Svizzera 1
Totale 19.757
Città #
Moscow 1.178
Ashburn 1.043
Singapore 914
Dublin 858
Chandler 684
Dallas 665
Jacksonville 551
Nyköping 500
Hong Kong 431
Beijing 405
Messina 338
Warsaw 253
The Dalles 229
San Jose 228
Los Angeles 160
Princeton 150
Ann Arbor 147
Lauterbourg 138
Medford 138
Cambridge 116
Des Moines 110
Boardman 104
New York 95
São Paulo 82
Buffalo 75
Munich 71
Dearborn 66
Jinan 64
Ho Chi Minh City 61
Tianjin 53
Guangzhou 49
Hanoi 45
Frankfurt am Main 44
Redondo Beach 44
Brussels 43
Shenyang 42
Rio de Janeiro 38
Woodbridge 38
Belo Horizonte 34
Seattle 33
Vienna 33
Wilmington 33
Brno 31
Tokyo 29
Nanjing 28
Orem 27
Santa Clara 27
Stockholm 27
Chennai 26
Hebei 26
Johannesburg 26
Catania 25
Milan 25
Zhengzhou 25
San Mateo 24
Council Bluffs 23
Rome 23
Shanghai 23
Brooklyn 22
Haikou 22
Houston 22
Changsha 20
Dong Ket 20
Lancaster 20
Taizhou 20
Turku 20
Amsterdam 19
Chicago 19
Montreal 19
Tashkent 19
London 18
Ningbo 17
Sorocaba 17
Düsseldorf 16
Jakarta 16
Brasília 15
Curitiba 15
Denver 15
Hyderabad 15
Nanchang 15
Phoenix 15
Saint Petersburg 15
Boston 14
Campinas 14
Helsinki 14
Nuremberg 14
Porto Alegre 14
Pune 14
Shenzhen 14
Atlanta 13
Hangzhou 13
Ribeirão Preto 13
San Francisco 13
Mumbai 12
Caxias do Sul 11
Fuzhou 11
Manchester 11
Modica 11
Taiyuan 11
Ankara 10
Totale 11.456
Nome #
HLA-C*17 in COVID-19 patients: hints for associations with severe clinical outcome and cardiovascular risk 256
A multivariate analysis of Multiple Myeloma subtype plasma cells 246
Symptomatic carotid atherosclerotic plaques are associated with increased infiltration of natural killer (NK) cells and higher serum levels of NK activating receptor ligands 243
Membrane transfer from tumor cells overcomes deficient phagocytic ability of plasmacytoid dendritic cells for the acquisition and presentation of tumor antigens. 206
Divergent signaling pathways regulate IL-12 production induced by different species of Lactobacilli in human dendritic cells 205
NCR(+)ILC3 concentrate in human lung cancer and associate with intratumoral lymphoid structures. 203
Acquisition and presentation of tumor antigens by dendritic cells. 196
A mixture of bacterial mechanical lysates is more efficient than single strain lysate and of bacterial-derived soluble products for the induction of an activating phenotype in human dendritic cells. 188
Curcumin ameliorates the in vitro efficacy of carfilzomib in human multiple myeloma U266 cells targeting p53 and NF-kB pathways 188
An historical overview: The discovery of how NK cells can kill enemies, recruit defense troops, and more 188
CD56(bright) CD16(-) killer Ig-like receptor(-) NK cells display longer telomeres and acquire features of CD56(dim) NK cells upon activation 187
Oxidative stress induces Wnt canonical/non-canonical pathways modulation in colon cancer cell models 186
Biological parameters in breast cancer 185
Characterization and functional analysis of the human microRNA 363 in glioblastoma transfected cell lines 181
Changes in plasma 5-HT levels and equine leukocyte SERT expression in response to treadmill exercise 180
Intralesional sonographically guided injections of lymphokine- activated killer cells and recombinant interleukin-2 for the treatment of liver tumors: A pilot study 179
Arginase 2 is expressed by human lung cancer, but it neither induces immune suppression, nor affects disease progression 175
A PHASE-I STUDY OF INTRAVESICAL CONTINUOUS PERFUSION OF RECOMBINANT INTERLEUKIN-2 IN PATIENTS WITH SUPERFICIAL BLADDER- CANCER 175
Cerebral venous sinus thrombosis (CVST) associated with SARS-CoV-2 vaccines: clues for an immunopathogenesis common to CVST observed in COVID-19 175
CLASS-I HLA AND ICAM-1 MOLECULE EXPRESSION IN PRIMARY CULTURED CANCER-CELLS DECREASES IN A STATIONARY-PHASE OF CELL-GROWTH 173
A non-canonical adenosinergic pathway led by CD38 in human melanoma cells induces suppression of T cell proliferation 173
Cross-dressing: an alternative mechanism for antigen presentation 173
Seroma fluid subsequent to axillary lymph node dissection for breast cancer derives from an accumulation of afferent lymph. 171
CD56(bright)perforin(low) noncytotoxic human NK cells are abundant in both healthy and neoplastic solid tissues and recirculate to secondary lymphoid organs via afferent lymph. 171
Mechanical bacterial lysate enhances antimicrobial barrier mechanisms in human airway epithelial cells 170
METALLIC MICROSPHERE CONJUGATED MONOCLONAL-ANTIBODIES SPECIFIC FOR A CELL-SURFACE DETERMINANT ENHANCE DAMAGE TO CANCER-CELLS EXPOSED TO SHOCK-WAVES 169
Natural killer cells in the innate immunity network of atherosclerosis. 169
Detection Of Lynphocytic β - Endorphin In Cancer Patients During Hospedalization And After In Vitro Culture With IL 2. 169
Biological parameters in breast cancer. 167
A think tank of TINK/TANKs: tumor-infiltrating/tumor-associated natural killer cells in tumor progression and angiogenesis 167
MiRNA expression profiling in human gliomas: upregulated miR-363 increases cell survival and proliferation 167
Human hepatitis B virus negatively impacts the protective immune cross-talk between natural killer and dendritic cells 165
Susceptibility of Human Melanoma Cells to Autologous Natural Killer (NK) Cell Killing: HLA-Related Effector Mechanisms and Role of Unlicensed NK Cells 164
Intralesional sonographically guided injections of lymphokine-activated killer cells and recombinant interleukin-2 for the treatment of liver tumors: a pilot study. 164
Circulating ILC precursors expressing CD62L exhibit a type 2 signature distinctly decreased in psoriatic patients 163
FCM detection of lymphocytic beta-endorphin in cancer patients during hospitalization and after in vitro culture with IL2 162
Dendritic cell recognition by ILC3 via DNAM-1 triggers pro-inflammatory reciprocal cell activations 161
Cutting Edge: Hyperinflammatory Monocytes Expressing CD56 Abound in Severe COVID-19 Patients 160
Human NK cells of mice with reconstituted human immune system components require pre-activation to acquire functional competence. 159
SPONTANEOUS TRANSFORMATION AND IMMORTALIZATION OF PERITONEAL- MACROPHAGES OF HUMAN-ORIGIN 159
Association Between Response to Nivolumab Treatment and Peripheral Blood Lymphocyte Subsets in Patients With Non-small Cell Lung Cancer 159
Potential effects of vaccinations on the prevention of COVID-19: rationale, clinical evidence, risks, and public health considerations 159
Myeloma cells induce the accumulation of activated CD94low NK cells by cell-to-cell contacts involving CD56 molecules 157
T cell polarizing properties of probiotic bacteria 155
Attenuated immune control of Epstein–Barr virus in humanized mice is associated with the multiple sclerosis risk factor HLA-DR15 153
Role of natural killer cells in the pathogenesis and progression of multiple sclerosis 152
CTLA-4 is expressed by human monocyte-derived dendritic cells and regulates their functions. 152
Cytotoxic effects of high energy shock waves on cancer cells linked to metallic beads vehicled by monoclonal antibodies 151
Evaluation of the canonical/non-canonical Wnt signalling pathways during oxidative stress in colorectal cancer cell line models 150
ILC in chronic inflammation, cancer and targeting with biologicals 150
Adherent neoplastic cells grown at confluence downregulate HLA class I expression and enhance their susceptibility to lysis mediated by natural killer cells 149
The anti-tumor activity of bacillus Calmette-Guerin in bladder cancer is associated with an increase in the circulating level of interleukin-2 148
Curcumin potentiates the antitumor activity of Paclitaxel in rat glioma C6 cells 146
Adaptative immunotherapy of advanced solid tumors 146
Crosstalk between ILC3s and Microbiota: Implications for Colon Cancer Development and Treatment with Immune Check Point Inhibitors 145
Adoptive immunotherapy of advanced solid tumors: An eight year clinical experience 143
In vitro VLA-4 blockade results in an impaired NK cell-mediated immune surveillance against melanoma 141
The Yin and Yang of Innate Lymphoid Cells in Cancer 141
FITC-labelled clone from phage display for direct detection of leukemia cells in blood 141
Correlation between Hyperkalemia and the Duration of Several Hospitalizations in Patients with Chronic Kidney Disease 140
Phytochemicals, Antioxidant and Antiproliferative Properties of Rosmarinus officinalis L on U937 and CaCo-2 Cells 139
Oxidative Stress Induces WNT Canonical/Non-Canonical Pathway Modulation in Colon Cancer Cells with APC or beta-Catenin Mutation 138
Human NK cells and NK receptors. 137
Potential predictive role of gut microbiota to immunotherapy in HCC patients: a brief review 136
Analysis of HLA-class-I specific natural killer cell receptors expressed on T lymphocytes infiltrating non-small-cell lung cancer 136
null 135
Anti-SARS-CoV2 IgG are present in the amniotic fluid of both infected and vaccinated women at second trimester of pregnancy: a cohort study 135
Monocyte to HDL ratio: a novel marker of resistant hypertension in CKD patients 135
In vitro modulation of lymphocytes ß-endorphin (ß-END) studied by flow cytometry. 135
Effect of oxidative stress on canonical/non-canonical WNT pathways in colon cancer cell lines 135
Detection of MAGE-1, -2 and -3 messenger RNA in tissue samples derived from lung and mammary tumors. 134
Characterization of human afferent lymph dendritic cells from seroma fluids. 133
Mucosal Immunology and Probiotics. 132
The Immune Inhibitory Receptor LAIR-1 Is Highly Expressed by Plasmacytoid Dendritic Cells and Acts Complementary with NKp44 to Control IFN-α Production 131
Role of natural killer and dendritic cell crosstalk in immunomodulation by commensal bacteria probiotics. 131
EMODERIVATO IN FORMA DI GEL COMPRENDENTE FIBRINA, PIASTRINE E LEUCOCITI 131
Interleukins 12 and 15 induce cytotoxicity and early NK-cell differentiation in type 3 innate lymphoid cells 130
Vitamin D and inflammatory bowel disease 129
Neutrophil-like Monocytes Increase in Patients with Colon Cancer and Induce Dysfunctional TIGIT+ NK Cells 128
Flavonoid profile, antioxidant and cytotoxic activity of different extracts from Algerian Rhamnus alaternus L. bark 125
Raman spectroscopy is able to discriminate between CD138-/CD138+ plasmacells of multiple myeloma patients. 125
Influence of Vitamin D in Advanced Non-Small Cell Lung Cancer Patients Treated with Nivolumab 124
Multiple Myeloma Cells Shift the Fate of Cytolytic ILC2s Towards TIGIT-Mediated Cell Death 123
Th17 skewing in the GALT of a Crohn disease patient upon Lactobacillus rhamnosus GG consumption 122
On immunostimulants and dendritic cell activation 120
Cognate HLA absence in trans diminishes human NK cell education 119
Molecular mechanisms directing migration and retention of natural killer cells in human tissues 119
Expansion of natural killer cells in patients with head and neck cancer: Detection of "noninhibitory" (activating) killer Ig-like receptors on circulating natural killer cells 117
EPS T14 from Bacillus licheniformis Prevents Infection of Human Nasal Epithelial Cells by Respiratory Viruses 116
MORPHOLOGICAL, PHENOTYPIC AND KARYOTYPIC CHARACTERIZATION OF A NOVEL NATURAL-KILLER-CELL TARGET - EVIDENCE OF INVOLVEMENT OF MHC CLASS-I MOLECULES IN NK CELL RECOGNITION 115
CD62L expression identifies a unique subset of polyfunctional CD56dim NK cells. 115
Phage-phenotype imaging of myeloma plasma cells by phage display 115
BNT162b2 COVID-19 vaccination elicits the expansion of CD16+CD8+ T cells endowed with natural killer cell features 114
Drag cells in immunity: Plasmacytoid DCs dress up as cancer cells. 114
NK cells provide helper signal for CD8+ T cells by inducing the expression of membrane-bound IL-15 on DCs 112
Identification of Natural Killer Cells in Tissues and Their Isolation 112
Chitosan/hyaluronan nanoparticles: a promising tool in cancer immunotherapy 109
Novel perspectives on dendritic cell-based immunotherapy of cancer. 109
T lymphocytes express B7 family molecules following interaction with dendritic cells and acquire bystander costimulatory properties 107
Natural Killers Are Made Not Born: How to Exploit NK Cells in Lung Malignancies 107
Totale 15.195
Categoria #
all - tutte 64.012
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 64.012


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021367 0 0 0 0 0 0 0 0 0 202 108 57
2021/2022941 15 157 17 31 46 16 74 52 14 64 130 325
2022/20232.633 232 261 119 217 195 260 37 163 1.030 10 63 46
2023/2024664 63 106 82 39 55 117 22 28 8 31 5 108
2024/20253.252 66 40 58 196 155 118 74 754 771 216 280 524
2025/20269.554 506 619 669 692 866 2.067 1.198 1.315 1.255 367 0 0
Totale 20.093